Daniel Raynor, Director at ANI PHARMACEUTICALS INC (ANIP), sold 12,528 shares at $61.50 ($761K) on 2018-03-15, disclosed to the SEC on 2018-03-19.
Open-market sale of $761k ANIP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $61.50 | 1,902 | $117K | 15.4% |
| 2 | $60.62 | 5,313 | $322K | 42.3% |
| 3 | $60.62 | 5,313 | $322K | 42.3% |
| Total | $60.75 avg | 12,528 | $761K | 100% |
| Filing → |
| ANIP | SELL | 2014-03-18 | $716K | — | Filing → |
| ANIP | SELL | 2014-03-18 | $418K | — | Filing → |
| ANIP | SELL | 2014-03-14 | $715K | — | Filing → |